Ogura, N., Yamamoto, S., Morita, R., Imazeki, H., Takahashi, H., Honma, Y., Kurita, D., Ishiyama, K., Daiko, H., Seto, Y., Kato, K. (2026). Comparison between nivolumab plus ipilimumab, FOLFOX and nivolumab plus FOLFOX therapy as first-line treatment for cisplatin-unfit advanced esophageal squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.388